Institute of Genomic Medicine
About Us
The Rutgers NJMS Clinical Genomics is the successor of the UMDNJ Institute of Genomic Medicine (founded in 1990). Our current staff of includes: board-certified clinical geneticists, board-certified genetic counselor, health educator, social workers and two registered dietitians.
We are committed to enabling translational research and personalized medicine through biomarker discovery, clinical development and commercialization. To this end, Rutgers NJMS Clinical Genomics functions as an academic contract research organization (CRO) dedicated to biomarker discovery and the clinical evaluation of biomarkers. As a CRO, we operate CLIA certified CAP accredited research and diagnostic laboratories and have substantial access to patients through the University Hospital, Behavioral Science Center and affiliated hospitals. The patient population has exceptional ethnic diversity. Our staff of physicians, clinical geneticists and genetic counselors has extensive experience in patient care and education.
Genetic discovery research infrastructure
Next Generation Sequencing, Microarray and other equipment for genomic research (expression profiling and genotyping).
Clinical biomarker validation & diagnostic test development
Offering clinical development of diagnostic biomarkers discovered by university faculty and industry partners in our CLIA-certified labs. Providing biomarker discovery and development services to biotechnology and pharmaceutical companies.
Clinical lab testing services for New Jersey hospitals through CLIA-certified clinical reference labs (also certified by the College of American Pathology)
Molecular Diagnostics
Clinical Genomics
Biochemical Diagnostics
Cytogenetics
Genetic counseling, newborn screening and outreach services to New Jersey hospitals
Provide evaluation and patient information for prenatal and postnatal diagnosis in pediatrics and obstetrics and adult onset disorders including heritable forms of cancer.
Support specialty clinics for neurofibromatosis, autism, cranial facial disorders, sickle cell disease, hemophilia, cystic fibrosis and muscular dystrophy.
